Maxim Group Downgrades BioRestorative Therapies to Hold
Maxim Group analyst Michael Okunewitch downgrades BioRestorative Therapies (NASDAQ:BRTX) from Buy to Hold.
Share
Why It Matters
An expert who liked this stock changed their mind to neutral. When experts lose confidence, it may mean they see fewer reasons to own it.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.